MA21.01 CBL Mutations (Mt) as Important Mediators of Oncogenic RTK Signaling in NSCLC

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.491
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Oncogenic Signaling by Leukemia-Associated Mutant CBL Proteins

Biochemistry & Analytical Biochemistry
2013English

K-Ras Mutation Subtypes in NSCLC and Associated Co-Occuring Mutations in Other Oncogenic Pathways

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

Oncogenic Mutations Rewire Signaling Pathways by Switching Protein Recruitment to Phosphotyrosine Sites

Cell
BiochemistryGeneticsMolecular Biology
2019English

MicroRNAs as Paracrine Signaling Mediators in Cancers and Metabolic Diseases

Best Practice and Research in Clinical Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2016English

Oncogenic Signaling in Gastric Carcinoma

2011English

New Driver Mutations Detected in NSCLC

Cancer Discovery
Oncology
2016English

Technique Pinpoints Oncogenic BRCA1 Mutations

Cancer Discovery
Oncology
2018English

SREBP1 Regulates Mitochondrial Metabolism in Oncogenic KRAS Expressing NSCLC

2020English

Analysis of Oncogenic Signaling Networks in Glioblastoma Identifies ASPM as a Molecular Target

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy